OBIGAIL

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Oct 2024 filing date already counts against anyone who files later.

Record

Serial number

98797472

Mark type

Stylized text

Filed

11 Oct 2024

Published for opposition

11 Nov 2025

Attorney of record

Mark A. Jansen

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations for the treatment of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Pharmaceuticals for the management of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications
• Class 041 — Education and entertainment services: Training services in the field of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; providing online non-downloadable articles, scientific papers, journals, brochures, leaflets, guides, manuals, videos, and multimedia content in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications
• Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software using artificial intelligence (AI) for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; software as a service (SAAS) services featuring software using agentic artificial intelligence (AI) for providing digital health services; software as a service (SAAS) services featuring software using agentic artificial intelligence (AI) for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software using artificial intelligence (AI) for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Software as a service (SAAS) services featuring software for the provision of healthcare services; Providing temporary use of online non-downloadable software for use in connecting patients with health counseling providers, therapists, medical support resources, and information regarding treatment of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Providing temporary use of online non-downloadable software for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software for facilitating medical consultancy services; Providing temporary use of online non-downloadable software for providing digital health services; Providing temporary use of online non-downloadable software for collecting, processing, and transmitting data between health care providers and patients; Providing temporary use of online non-downloadable software for enabling patients to view upcoming medical procedures, prepare for office visits, request medical tests, schedule and confirm medical appointments, and receive assistance with appointment logistics; Providing temporary use of online non-downloadable software for accessing information in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software using artificial intelligence technology for data analytics for use in connection with health counseling, therapy, support, and treatment; Providing temporary use of online non-downloadable software for managing the provision of healthcare services for use in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for medical research; Scientific and technological services, namely, research and development in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Research and development of pharmaceuticals
• Class 044 — Medical, beauty and agricultural services: Healthcare services, namely, providing medical treatment in the fields of early pregnancy loss, miscarriage, infertility, and pregnancy complications; Healthcare services, namely, a patient assistance program providing pharmaceuticals for the treatment of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing medical information in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical services; Pharmaceutical compounding services; Medical advisory services; Medical consultation and counseling services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical consultations and therapy provided via website, phone, online chat or videoconferencing; Telemedicine services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Women's health care and wellness services, namely, providing online information related to health care and wellness services; Preparation and dispensing of medications

Owner

• Avila Science, Inc., New York, NY, US
• Avila Science, Inc., New York, NY, US

Prosecution history

• 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 11 Nov 2025 — PUBLISHED FOR OPPOSITION
• 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 15 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 08 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 29 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 29 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 15 Jul 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 15 Jul 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 15 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 15 Apr 2025 — NON-FINAL ACTION E-MAILED
• 15 Apr 2025 — NON-FINAL ACTION WRITTEN
• 15 Apr 2025 — ASSIGNED TO EXAMINER
• 14 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED